Study of drug resistance in HIV patients whose treatment is failing
Part of Immune system & allergy, Infections clinical trials.
This study looks at HIV drug resistance in people whose current HIV treatment is not keeping the virus under control. It helps doctors understand why some treatments stop working and how to choose better next steps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must be willing to take part in the study and give your permission.
- You must have been taking HIV medications for at least 6 months.
- Your last two or more blood tests must show a viral load above 50 copies/mL, meaning the treatment is not fully controlling the virus.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an observational study that follows people with HIV who are taking HIV medicines (antiretroviral therapy). It may help researchers understand how treatment is going and what factors relate to doing well on therapy.
This trial tests different ways to manage “virologic failure,” meaning HIV viral load stays high while taking TLD (a common HIV medicine combination). It may help people better control the virus and improve treatment results, especially in parts of sub-Saharan Africa.
This study follows people with HIV whose virus is well-controlled on current medications to understand how switching to a different HIV drug regimen affects the virus's ability to resist those drugs. The goal is to help doctors choose the safest treatment switches.
This is an observational study (not a new drug) that tracks how living with HIV can change over time in different treatment situations. It may help researchers understand long-term effects of the modern “protease inhibitor era” and improve future care.
This study looks at whether certain genetic changes in the HIV virus (called drug resistance mutations) affect how well your immune system recovers after you start HIV treatment. It could help doctors understand why some people on HIV therapy have better immune recovery than others.
This study looks at HIV in people who have just been diagnosed. It checks for drug resistance (whether the virus is resistant to certain medicines) and how the virus spreads, which can help doctors choose the best treatment for you and others.
Hear when a new HIV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.